These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A comparison of childhood and adult type I diabetes mellitus. Karjalainen J; Salmela P; Ilonen J; Surcel HM; Knip M N Engl J Med; 1989 Apr; 320(14):881-6. PubMed ID: 2648146 [TBL] [Abstract][Full Text] [Related]
23. [Islet cell (ICA), insulin (IAA) and other autoantibodies in type I diabetic patients and their families: prevalence and clinical correlation]. Becker F; Helmke K; Bretzel R; Seggewiss K; Sauer H; Federlin K Verh Dtsch Ges Inn Med; 1988; 94():1-6. PubMed ID: 3061184 [No Abstract] [Full Text] [Related]
24. Genetic and immunological characteristics of Type I diabetes mellitus in an Indo-Aryan population. Kelly MA; Alvi NS; Croft NJ; Mijovic CH; Bottazzo GF; Barnett AH Diabetologia; 2000 Apr; 43(4):450-6. PubMed ID: 10819238 [TBL] [Abstract][Full Text] [Related]
25. Islet cell antibodies and diabetes in Nigerians. Oli JM; Bottazzo GF; Doniach D Trop Geogr Med; 1981 Jun; 33(2):161-4. PubMed ID: 7025394 [TBL] [Abstract][Full Text] [Related]
26. [Etiology and pathogenesis of insulin-dependent diabetes mellitus]. Klöppel G; Clemens A Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059 [TBL] [Abstract][Full Text] [Related]
27. Type I diabetes mellitus. Pigrau C; Lorente A; Martinez-Vazquez JM N Engl J Med; 1986 Dec; 315(24):1552. PubMed ID: 3537788 [No Abstract] [Full Text] [Related]
28. [Autoantibodies to the pancreatic islet cells in type-1 diabetes mellitus]. Zlobina EN; Esenin VI; Demin IuM; Minkin SA Sov Med; 1988; (12):21-3. PubMed ID: 2468188 [No Abstract] [Full Text] [Related]
29. Evolution of the Pittsburgh studies of the epidemiology of insulin-dependent diabetes mellitus. Pittsburgh Diabetes Epidemiology and Etiology Research Group. Kuller LH; Becker DJ; Cruickshanks KJ; Dorman JS; Eberhardt MS; Drash AL; LaPorte RE; Lipton R; Moy C; O'Leary LA Genet Epidemiol; 1990; 7(2):105-19. PubMed ID: 2186962 [TBL] [Abstract][Full Text] [Related]
30. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease]. Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777 [TBL] [Abstract][Full Text] [Related]
36. The natural history and predictive value of Mr 64,000 autoantibodies for insulin-dependent diabetes mellitus. Atkinson MA; Maclaren NK; Holmes L; Scharp DW; Lacy PE; Riley WJ J Autoimmun; 1990 Apr; 3 Suppl 1():41-5. PubMed ID: 2187459 [No Abstract] [Full Text] [Related]
37. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Gorus FK Diabetes Metab Rev; 1997 Dec; 13(4):247-74. PubMed ID: 9509278 [No Abstract] [Full Text] [Related]
38. Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Genovese S; Bingley PJ; Bonifacio E; Christie MR; Shattock M; Bonfanti R; Foxon R; Gale EA; Bottazzo GF Lancet; 1994 Sep; 344(8924):756. PubMed ID: 7915802 [No Abstract] [Full Text] [Related]
39. Factors of importance for residual beta-cell function in type I diabetes mellitus. A review. Madsbad S Acta Med Scand Suppl; 1983; 671():61-7. PubMed ID: 6349267 [No Abstract] [Full Text] [Related]
40. Developmental regulation of serum interleukin-2 receptor concentrations: attenuation of the childhood peak in patients at risk for developing or having recently developed type I diabetes mellitus. Keller RJ; Jackson RA J Pediatr; 1989 May; 114(5):816-9. PubMed ID: 2654349 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]